B. Braun Medical has announced its production facility in taken an important step: its Crissier, Switzerland, has received FDA approval, which will allow the company to export its active ingredient HES 450 to the United States.
Crissier is B. Braun's first European production facility to be granted FDA approval for pharmaceutical products.
In order to be approved for U.S. marketing, law mandates that medical and pharmaceutical products originate from manufacturers that have been inspected by the FDA and found to comply with their high standards.
Learn more about B. Braun.